Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

IDS Medical Systems Philippines, Inc.'s Corporate Excellence has been Acknowledged at the Asia Pacific Enterprise Awards 2023 Regional Edition

SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- In a dazzling celebration of regional excellence, the Asia Pacific Enterprise Awards (APEA) 2023 Regional Edition took center stage to honor outstanding businesses and visionary leaders who have played a pivotal role in propelling their enterprises to new ...

2023-12-18 10:08 1420

Dr. Steve Mark Gan and His Company GAOC Group of Companies Claim Victory at the Asia Pacific Enterprise Awards 2023 Regional Edition

SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- The Asia Pacific Enterprise Awards (APEA) 2023 Regional Edition served as a magnificent tribute to exceptional businesses and forward-thinking leaders in the region. Following the Asia Economic Forum (AEF) 2023 inSingapore, which convened over 300 delegate...

2023-12-18 10:06 1440

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

YOGIN, South Korea, Dec. 17, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, formerly referred to as "GC5107," for the treatment of adult patients aged 17...

2023-12-18 09:49 1248

GeneQuantum and BioMap establish a strategic collaboration to jointly develop a series of next-generation ADC therapeutics

SUZHOU, China, Dec. 17, 2023 /PRNewswire/ -- Recently, GeneQuantum Healthcare (GQ), a global leader in ADC new drug development focused on innovative bioconjugation technologies, and BioMap, a global leader in life science AI Foundation protein-centric Large Language Models, announced that the...

2023-12-18 09:43 1157

Mediwave Unveils World's First Mixed Reality & AI-Powered Connected Ambulance

SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- In a groundbreaking development, Mediwave, the digital healthcare arm of Wavenet, headquartered inSingapore, partners with 1990 Suwa Seriya,Sri Lanka's national pre-hospital emergency ambulance service, to elevate life-enhancing emergency care through Mixe...

2023-12-18 08:00 1704

Mediwave Unveils World's First Mixed Reality & AI-Powered Connected Ambulance

Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications

ROCKVILLE, Md. and SUZHOU, China, Dec. 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2023-12-18 08:00 5772

Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications

First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

SHANGHAI, Dec. 17, 2023 /PRNewswire/ -- YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company's firstin vivo genome editing candidate being developed as a single dose, potentially curative therapy for hereditary transthyretin amyloidosis with cardio...

2023-12-17 23:15 1307

Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction

TAIPEI, Dec. 16, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that it has closed an oversubscribed capital raise, securing over$100M by issuing 8 million new shares. The new funding will enable Caliway to advance the clinical development of its lead pipeline CBL-514, a sma...

2023-12-16 15:47 1788

Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)

Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment JENA, Germany, Dec. 16, 2023 /PRNewswire/ -- Carl Zeiss Meditec AG announced today that it has entered into an agreement to acquire 100% of the shar...

2023-12-16 03:20 5744

Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)

Ubie Won the "Best with AI" in Google Play Best of 2023 (Japan)

NEW YORK, Dec. 15, 2023 /PRNewswire/ -- Ubie, Inc., headquartered at 1460 Broadway,New York, NY 10036 and led by CEO Kota Kubo, proudly announces that the Japanese version of Ubie's AI Symptom Checker (https://ubie.app/ ) has been awarded the "Best with AI" at the Google Play ...

2023-12-16 00:00 1980

Wandong Medical's full-line products obtain the MDR certification, facilitating its entry to the European market

BEIJING, Dec. 15, 2023 /PRNewswire/ -- Recently, Wandong's seven major series of products obtained the MDR certificate, following the completion of the first MDR certification for superconducting magnetic resonance. So far, Wandong's full range of X-ray, CT and MRI products have been completed t...

2023-12-15 21:10 2523

Wandong Medical's full-line products obtain the MDR certification, facilitating its entry to the European market

SeekIn and OncoInv Collaborate to Expand the Global Accessibility of Multiple Cancer Detection Tests and Bridge Global Disparities in Cancer Care

SeekIn to Grant Oncolnv the Rights to Represent SeekIn's Comprehensive Range of Cancer Detection Tests in Twelve Countries to Provide Individuals with Accessible and Affordable Cancer Detection Tests SHENZHEN, China, Dec. 15, 2023 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early ...

2023-12-15 21:00 1283

Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023

HONG KONG, Dec. 15, 2023 /PRNewswire/ -- Akeso published two phase Ib clinical results of its innovative CD47 monoclonal antibody ligufalimab (AK117) in combination with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) and treatment-naïve acute myeloid le...

2023-12-15 21:00 1358

BioSURE Pro Protective Nasal Spray from the UK: Block airborne viruses instantly for six hours with a Gentle Lavender Scent

HONG KONG, Dec. 15, 2023 /PRNewswire/ -- The weather was gradually cooling down, which means thatHong Kong is entering the winter influenza season. Recently, there has been a significant increase in Mycoplasma pneumoniae infections, the surveillance data from the Centre for Health Protection (CHP...

2023-12-15 20:21 2376

BioSURE Pro Protective Nasal Spray from the UK: Block airborne viruses instantly for six hours with a Gentle Lavender Scent

Tianlong Solution Facilitates the Prevention and Control of Livestock Diseases

XI'AN, China, Dec. 15, 2023 /PRNewswire/ -- It was recently announced that Tianlong Technology complies with the requirements of Chinese Good Manufacturing Practices for animal drugs. This approval further ensures Tianlong's focus on standardized workflows in the development of animal products. ...

2023-12-15 19:23 1803

Tianlong Solution Facilitates the Prevention and Control of Livestock Diseases

Ping An Receives Hong Kong ESG Excellence Awards 2023

HONG KONG and SHANGHAI, Dec. 15, 2023 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has won the ESG Excellence Awards 2023 in the category of Main Board Companies – Hang Seng Index Constituent C...

2023-12-15 15:41 4060

Addressing the Rising Myopia Challenge: HOYA Lens Singapore's MiYOSMART Sun with Full Control Lenses

SINGAPORE, Dec. 15, 2023 /PRNewswire/ -- HOYA Lens Singapore , a global leader in optical technology innovation, has introducedMiYOSMART Sun with Full Control lenses, the latest addition to its myopia management range. The lenses are specifically designed to addre...

2023-12-15 12:00 2059

Addressing the Rising Myopia Challenge: HOYA Lens Singapore's MiYOSMART Sun with Full Control Lenses

Live from ASH 2023 | Oral Report Featuring Encouraging Data of Olverembatinib Combined with Reduced-Intensity Chemotherapy in Patients with Ph+ ALL Presented at the ASH Annual Meeting

SUZHOU, China and ROCKVILLE, Md., Dec. 14, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today thatProf. Xiaoyuan Gong of the Institute of Hemato...

2023-12-15 11:14 1614

BIOCHEETAH ANNOUNCES EXCLUSIVE LICENSING AND COMMERCIALISATION AGREEMENT WITH NIPPON KAYAKU FOR VECanDx™ IN JAPAN

SINGAPORE and TOKYO, Dec. 15, 2023 /PRNewswire/ -- BioCheetah Pte. Ltd. (Head Office:Singapore; CEO: Dr. Lee Kian Chung; hereinafter "BioCheetah") and Nippon Kayaku Co., Ltd. (Head Office:Tokyo; President: Mr. Atsuhiro Wakumoto; hereinafter "Nippon Kayaku") announce that the two companies have en...

2023-12-15 09:40 1872

Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC)

* Nona Biosciences will receive a total of up to $53 Million in upfront and near-term payments, with the potential for milestones of up to$1.05 billion plus royalties. * Pfizer partnership expands Nona's global network of collaborations, reinforcing its commitment to providing cutting-edge te...

2023-12-15 07:30 1313

1 ... 50 51 525354 55 56 ... 807